Hematologic disorders comprise a vast category of diseases that affect millions of Americans and have a significant impact on the lives of individuals, their loved ones and the U.S. healthcare system ...

Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.

Hematologic tests help diagnose diseases of the blood and bone marrow cells, such as anemia, infection, hemophilia, blood-clotting disorders, leukemia, lymphoma, and myeloma. Common hematology tests ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...

The US Food and Drug Administration (FDA) on Thursday finalized guidance on the nonclinical studies drugmakers should conduct when developing products to treat severely debilitating or ...

Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola virus disease (EVD) and are characterized by one or several abnormalities in ...

Early longitudinal specialist-delivered inpatient palliative care for patients with AML and those undergoing HSCT has been shown to decrease anxiety, depression, and post traumatic stress disorder ...

Older patients often face financial challenges on fixed incomes with different payer systems like Medicare, Sarah Wall, MD, The Ohio State University Comprehensive Cancer Center, says. Accessing ...

At Huntsman Cancer Institute, you receive expert, highly specialized care for benign bleeding and clotting disorders. Your care team includes hematologists, nurse coordinators, social workers, ...

Nabsys 2.0, LLC ("Nabsys"), a pioneer in electronic genome mapping (EGM) technology, today announced a multi-year research collaboration with the Indiana University School of Medicine to develop and ...